-
Daré Bioscience Announces Phase 3 Plans for Sildenafil Cream, 3.6%, in the Treatment of Female Sexual Arousal Disorder (FSAD)
16 Dec 2024 13:00 GMT
… trial for the treatment of female sexual arousal disorder.” The Journal of Sexual … Cream for the Treatment of Female Sexual Arousal Disorder: A Randomized Controlled Trial.” … ingredient in Viagra®, to treat female sexual arousal disorder (FSAD); and DARE-HRT1, …
-
Sildenafil cream demonstrates safety, efficacy in phase 2b study for female sexual arousal disorder
11 Dec 2024 16:55 GMT
… , an investigational topical treatment for female sexual arousal disorder (FSAD). The findings, published in … cream for the treatment of female sexual arousal disorder. Sex Med. 2024 Nov 19 …
-
Research Study Opportunity: Investigational medication for the treatment of Female Sexual Arousal Disorder (FSAD) in postmenopausal women
04 Sep 2024 00:08 GMT
… medication for the treatment of Female Sexual Arousal Disorder (FSAD) in postmenopausal women who …
-
Daré Bioscience, Inc. (NASDAQ:DARE) Q4 2024 Earnings Call Transcript
01 Apr 2025 13:10 GMT
… Cream as a treatment for female sexual arousal disorder in women. Bringing our … indication for the treatment of female sexual arousal disorder, because until you have … indicated for the treatment of female sexual arousal disorder in premenopausal women, right? …
-
Topical sildenafil cream may improve outcomes among women with female sexual arousal disorder, claims study
13 Jul 2024 01:18 GMT
… included women with only female sexual arousal disorder and those with female sexual arousal disorder with concomitant sexual … cream, improve, outcomes, among, women, female, sexual, arousal disorder, study, Obstetrics & Gynecology, Johnson …
-
Daré Bioscience Reports Full Year 2024 Financial Results and Provides Company Update
31 Mar 2025 20:01 GMT
… as a treatment for female sexual arousal disorder. Our proprietary formulation would … on-demand administration to treat female sexual arousal disorder (FSAD).
Continued operational … in Viagra®, to treat female sexual arousal disorder (FSAD); and DARE-HRT1 …
-
Daré Bioscience Announces Publication in Obstetrics & Gynecology of Phase 2b Study Efficacy Results of Topical Sildenafil Cream, 3.6% for the Treatment of Female Sexual Arousal Disorder
24 Jun 2024 12:00 GMT
… improved outcomes among women with female sexual arousal disorder (FSAD), particularly in … for the treatment of female sexual arousal disorder (FSAD). The Phase … Cream for the Treatment of Female Sexual Arousal Disorder: A Randomized Controlled Trial …
-
What is female sexual arousal disorder? Know its causes and how to fix it
27 Apr 2024 04:44 GMT
… is a symptom of female sexual arousal disorder. Image courtesy: FreepikWhat … treat female sexual arousal disorder?
Here are some ways to treat female sexual arousal disorder:
1 … is beneficial when treating female sexual arousal disorder. “Reduced arousal and …
-
Daré Bioscience Announces Positive End-of-Phase 2 Meeting with FDA on Development of Sildenafil Cream, 3.6% in Female Sexual Arousal Disorder and Provides Company Focus Areas for 2024
31 Jan 2024 13:00 GMT
… Cream) for the treatment of female sexual arousal disorder (FSAD) to a Phase 3 … ingredient in Viagra®, to treat female sexual arousal disorder (FSAD); and DARE-HRT1, a …
-
Daré Bioscience to Host Full Year 2024 Financial Results and Company Update Conference Call and Webcast on March 31, 2025
24 Mar 2025 12:00 GMT
… ingredient in Viagra®, to treat female sexual arousal disorder (FSAD); and DARE-HRT1, a …
About
© 1995-2025